CAROLYN LE: Open Payments
NPI 1477212728 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,945 in 153 payments from 15 companies in 2025. Trend: 2023 $3,156 · 2024 $2,514 · 2025 $2,945
Food & beverage: $2,945
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 38 | $657 |
| ABBVIE INC. | 29 | $443 |
| Alkermes, Inc. | 14 | $299 |
| Teva Pharmaceuticals USA, Inc. | 16 | $280 |
| Vanda Pharmaceuticals Inc. | 12 | $269 |
| Lundbeck LLC | 11 | $232 |
| Axsome Therapeutics, Inc. | 7 | $153 |
| E.R. Squibb & Sons, L.L.C. | 5 | $150 |
| Indivior Inc. | 4 | $107 |
| Neurocrine BioSciences, Inc. | 4 | $107 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, FANAPT, REXULTI, UZEDY, Auvelity, COBENFY.
Industry payments across CA — which companies pay providers there.
